We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
China, Global, United Kingdom, USA - February 27 2013
Pharmaceutical and biologic manufacturers operate in an increasingly global economy where legal developments in one market may have cascading impacts…
USA - October 16 2012
The Office of the Inspector General of the U.S. Department of Health and Human Services ("OIG") released its annual Work Plan for Fiscal Year 2013 on October 2, 2012 ("the Work Plan").
USA - July 12 2012
Earlier this week, Massachusetts Governor Deval Patrick approved the state’s fiscal year 2013 budget, which authorizes three significant changes of importance to pharmaceutical and medical device manufacturers.
USA - June 28 2012
In a splintered decision, the Supreme Court upheld the individual mandate of the Patient Protection and Affordable Care Act (“ACA”) but partially invalidated the Act’s expansion of Medicaid.
China, European Union, France, Germany, United Kingdom, USA - May 18 2012
Sidley Austin LLP’s Global Life Sciences Team is pleased to provide you with this Global Pricing Newsletter, the first in a periodic series updating clients and friends of the firm on pricing issues around the world that may have an impact on pharmaceutical and biologic manufacturers’ legal and business strategies.
